Expression of survivin in B cells might be attributable to adverse cell recognition in RA, since changes in survivin expression after therapeutic B cell depletion was associated with a reduction of B cell numbers, serum levels of rheumatoid factor (RF) and the activity of arthritis [32]. Here, BIRC5 is linked to rheumatoid arthritis.